titlesubmit dateissue date
Now showing items 1-9 of 9
Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases.
Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma
Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype.
Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth
NFATc3 controls tumour growth by regulating proliferation and migration of human astroglioma cells
Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma
Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.
The EGFR-TMEM167A-p53 Axis Defines the Aggressiveness of Gliomas
Tumor-derived pericytes driven by EGFR mutations govern the vascular and immune microenvironment of gliomas.